z-logo
Premium
Fat‐soluble vitamins in infants identified by cystic fibrosis newborn screening
Author(s) -
Sokol Ronald J.,
Reardon Mary C.,
Accurso Frank J.,
Stall Charlotte,
Narkewicz Michael R.,
Abman Steven H.,
Hammond Keith B.
Publication year - 1991
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.1950110711
Subject(s) - cystic fibrosis , medicine , fat soluble vitamin , vitamin , vitamin d deficiency , vitamin a deficiency , retinol , vitamin d and neurology , newborn screening , vitamin k deficiency , pancreatic enzymes , pancreatic disease , endocrinology , gastroenterology , physiology , pediatrics , pancreas
Fat‐soluble vitamin status was assessed in 36 infants diagnosed with cystic fibrosis by newborn screening in the Colorado Program. At the time of diagnosis of cystic fibrosis, 36% of infants were hypoalbuminemic, 21% had vitamin A deficiency, 35% had vitamin D deficiency, and 38% had vitamin E deficiency. None had vitamin K deficiency. Supplementation with pancreatic enzymes, a multiple vitamin preparation, and additional vitamin E was associated with normalization of serum albumin, retinol, and 25‐hydroxyvitamin D and negative PIVKA testing at age 6 and 12 months. Several patients remained vitamin E deficient, but this was felt to be due to poor compliance. Biochemical evidence of fat‐soluble vitamin deficiency is common before age 3 months in infants with CF and responds to supplementation in the first year of life. Pediatr Pulmonol. 1991; Supp 7: 52–55.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom